Serum sulfotransferase levels in patients with macular corneal dystrophy type I

Archives of Ophthalmology

Volumn 115, Issue 11, 1997, Pages 1419-1421

  Hassell, John R ^a,b   Klintworth, Gordon K ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Sfiriiiers Hospital/or Children   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; CHONDROITIN SULFATE; KERATAN SULFATE; N ACETYLGLUCOSAMINE; SULFOTRANSFERASE; SULFUR 35;

ADULT; ARTICLE; CONTROLLED STUDY; CORNEA DYSTROPHY; CORNEA STROMA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SULFATION;

EID: 0031442423     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100160589011     Document Type: Article

References (13)

1. Klintworth GK. Disorders of glycosaminoglycans (mucopolysaccharides) and proteoglycans. In: Garner A, Klintworth GK, eds. Pathotiology of Ocular Disease. 2nd ed. New York, NY: Marcel Dekker Inc; 1994:855-892.
2. Hassell JR, Newsome DA, Krachmer JH, Rodrigues MM. Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. ProcNatlAcad Sei US A. 1980:77:3705-3709.
3. Klintworth GK, Smith CF. Abnormalities of proteoglycans and glycoproteins synthesized by corneal organ cultures derived from patients with macular corneal dystrophy. Lab Invest. 1983:48:603-612.
4. Nakazawa K, Hassell JR, Hascall VC, Lohmander LS, Newsome DA, Krachmer J. Defective processing of keratan sulfate in macular corneal dystrophy. JBiolChem. 1984:259:13751-13757.
5. Midura RJ, Hascall VC, MacCallum DK, et al. Proteoglycan biosynthesis by human corneas from patients with types I and II macular corneal dystrophy. JBiol Chem. 1990:265:15947-15955.
6. Thonar EJ-MA, Meyer RF, Dennis RF, et al. Absence of normal keratan sulfate in the blood of patients with macular corneal dystrophy. Am J Ophthalmol. 1986: 102:561-569.
7. Thonar EJ-MA, Williams JM, Sweet MBE, et al. Serum keratan sulfate concentration as a measure of the catabolism of cartilage proteoglycan. In: Kresina TF, ed. Monoclonal Antibodies and Immunotherapy in Arthritis: Clinical and Experimental Aspects. New York, NY: Marcel Dekker Inc; 1990:373-398.
8. Inoue H, Otsu K, Yoneda M, Kimata K, Suzuki S, Nakanishi Y. Glycosaminoglycan sulfotransferases in human and animal sera. J Biol Chem. 1986:261:44604469.
9. Rüter E-R, Kresse H. Partial purification and characterization of 3'-phosphoadenylylsulfate: keratan sulfate sulfotransferases. J Biol Chem. 1984;259: 11771-11776.
10. Rada JA, Cornuet PK, Hassell JR. Regulation of corneal collagen fibrinogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res. 1993:56:635-648.
11. Sugahara K, Nakamura M, Nagisa J, et al. Regulation of serum glycosaminoglycan sulfotransferase activities: inhibition by sulfated glycosaminoglycans and activation by polyamine and basic peptides including a polysine-containing segment of the c-Ke-ras 2 protein. J Biochem. 1989;106:910-919.
12. Fukata M, Uchimura K, Nakashima K, et al. Molecular cloning and expression of chick chondrocytechondroitin6-sulfotransferase../B/o/C/;e/n. 1995:270:1857518580.
13. Habuchi 0, Hirahara Y, Uchimura K, Fukuta M. Enzymatic sulfation of galactose residue of keratan sulfated by chondroitin 6-sulfotransferase. Glycobio/ogy. 1996; 6:51-57.